Page 208 - Cellular Imaging in Regenerative Medicine, Cancer and Osteoarthritis
P. 208

                                Chapter 11
Hoving S, van Tiel ST, Eggermont AM, ten Hagen TL. Effect of low-dose tumor necrosis factor-alpha in combination with STEALTH liposomal cisplatin (SPI- 077) on soft-tissue- and osteosarcoma-bearing rats. Anticancer Res. 2005 Mar- Apr;25(2A):743-50.
van Etten B, Eggermont AM, van Tiel ST, Ambagtsheer G, de Wilt JH, ten Hagen TL. Gene therapy in in vivo isolated perfusion models. Curr Gene Ther. 2005 Apr;5(2):195-202.
Brunstein F, Hoving S, Seynhaeve AL, van Tiel ST, Guetens G, de Bruijn EA, Eggermont AM, ten Hagen TL. Synergistic antitumor activity of histamine plus melphalan in isolated limb perfusion: preclinical studies. J Natl Cancer Inst. 2004 Nov 3;96(21):1603-10.
Preda A, Wielopolski PA, Ten Hagen TL, van Vliet M, Veenland JF, Ambagtsheer G, van Tiel ST, Vogel MW, Eggermont AM, Krestin GP, van Dijke CF. Dynamic contrast-enhanced MRI using macromolecular contrast media for monitoring the response to isolated limb perfusion in experimental soft-tissue sarcomas. MAGMA. 2004 Dec;17(3-6):296-302
van Etten B, Eggermont AM, Ambagtsheer G, van Tiel ST, ten Hagen TL. Impaired neutralising antibody formation and high transduction efficacy after isolated hepatic perfusion with adenoviral vectors. Br J Cancer. 2004 Oct 18;91(8):1610-3.
Van Etten B, Van Tiel ST, Ambagtsheer G, Eggermont AM, Ten Hagen TL. Isolated limb perfusion based anti-p21ras gene therapy in a rat rhabdomyosarcoma. Anticancer Res. 2004 Jul-Aug;24(4):2295-301.
ten Hagen TL, Hoving S, Ambagtsheer G, van Tiel ST, Eggermont AM. Lack of efficacy of Doxil in TNF-alpha-based isolated limb perfusion in sarcoma- bearing rats. Br J Cancer. 2004 May 4;90(9):1830-2.
206


























































































   206   207   208   209   210